Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04090229
Brief Title: A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis

First Submitted : September 11, 2019
First Submitted that Met QC Criteria : September 13, 2019
First Posted : September 16, 2019

Last Update Submitted that Met QC Criteria : April 22, 2021
Last Update Posted : April 23, 2021